1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer

R Stahel; N Thatcher; M Früh; C Le Péchoux; P E Postmus; J B Sorensen; E Felip; Panel members

doi:http://dx.doi.org/10.1093/annonc/mdr313

1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer

R Stahel, N Thatcher, M Früh, C Le Péchoux, P E Postmus, J B Sorensen, E Felip, Panel members

42 Citationer (Scopus)

Abstract

The 1st ESMO Consensus Conference on lung cancer was held in Lugano, Switzerland on 21st and 22nd May 2010 with the participation of a multidisciplinary panel of leading professionals in pathology and molecular diagnostics and medical, surgical and radiation oncology. Before the conference, the expert panel prepared clinically relevant questions concerning five areas as follows: early and locally advanced non-small-cell lung cancer (NSCLC), first-line metastatic NSCLC, second-/third-line NSCLC, NSCLC pathology and molecular testing, and small-cell lung cancer (SCLC) to be addressed through discussion at the Consensus Conference. All relevant scientific literature for each question was reviewed in advance. During the Consensus Conference, the panel developed recommendations for each specific question. The consensus agreement in SCLC is reported in this article. The recommendations detailed here are based on an expert consensus after careful review of published data. All participants have approved this final update.

Originalsprog	Engelsk
Tidsskrift	Annals of Oncology
Vol/bind	22
Udgave nummer	9
Sider (fra-til)	1973-80
Antal sider	8
ISSN	0923-7534
DOI	https://doi.org/10.1093/annonc/mdr313
Status	Udgivet - sep. 2011

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

http://dx.doi.org/10.1093/annonc/mdr313

Citationsformater

@article{39aa59b3847c417c88d938443f2b2431,

title = "1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer",

abstract = "The 1st ESMO Consensus Conference on lung cancer was held in Lugano, Switzerland on 21st and 22nd May 2010 with the participation of a multidisciplinary panel of leading professionals in pathology and molecular diagnostics and medical, surgical and radiation oncology. Before the conference, the expert panel prepared clinically relevant questions concerning five areas as follows: early and locally advanced non-small-cell lung cancer (NSCLC), first-line metastatic NSCLC, second-/third-line NSCLC, NSCLC pathology and molecular testing, and small-cell lung cancer (SCLC) to be addressed through discussion at the Consensus Conference. All relevant scientific literature for each question was reviewed in advance. During the Consensus Conference, the panel developed recommendations for each specific question. The consensus agreement in SCLC is reported in this article. The recommendations detailed here are based on an expert consensus after careful review of published data. All participants have approved this final update.",

author = "R Stahel and N Thatcher and M Fr{\"u}h and {Le P{\'e}choux}, C and Postmus, {P E} and Sorensen, {J B} and E Felip and S{\o}rensen, {Jens Benn}",

year = "2011",

month = sep,

doi = "http://dx.doi.org/10.1093/annonc/mdr313",

language = "English",

volume = "22",

pages = "1973--80",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "Oxford University Press",

number = "9",

}

TY - JOUR

T1 - 1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer

AU - Stahel, R

AU - Thatcher, N

AU - Früh, M

AU - Le Péchoux, C

AU - Postmus, P E

AU - Sorensen, J B

AU - Felip, E

AU - Panel members

PY - 2011/9

Y1 - 2011/9

N2 - The 1st ESMO Consensus Conference on lung cancer was held in Lugano, Switzerland on 21st and 22nd May 2010 with the participation of a multidisciplinary panel of leading professionals in pathology and molecular diagnostics and medical, surgical and radiation oncology. Before the conference, the expert panel prepared clinically relevant questions concerning five areas as follows: early and locally advanced non-small-cell lung cancer (NSCLC), first-line metastatic NSCLC, second-/third-line NSCLC, NSCLC pathology and molecular testing, and small-cell lung cancer (SCLC) to be addressed through discussion at the Consensus Conference. All relevant scientific literature for each question was reviewed in advance. During the Consensus Conference, the panel developed recommendations for each specific question. The consensus agreement in SCLC is reported in this article. The recommendations detailed here are based on an expert consensus after careful review of published data. All participants have approved this final update.

AB - The 1st ESMO Consensus Conference on lung cancer was held in Lugano, Switzerland on 21st and 22nd May 2010 with the participation of a multidisciplinary panel of leading professionals in pathology and molecular diagnostics and medical, surgical and radiation oncology. Before the conference, the expert panel prepared clinically relevant questions concerning five areas as follows: early and locally advanced non-small-cell lung cancer (NSCLC), first-line metastatic NSCLC, second-/third-line NSCLC, NSCLC pathology and molecular testing, and small-cell lung cancer (SCLC) to be addressed through discussion at the Consensus Conference. All relevant scientific literature for each question was reviewed in advance. During the Consensus Conference, the panel developed recommendations for each specific question. The consensus agreement in SCLC is reported in this article. The recommendations detailed here are based on an expert consensus after careful review of published data. All participants have approved this final update.

U2 - http://dx.doi.org/10.1093/annonc/mdr313

DO - http://dx.doi.org/10.1093/annonc/mdr313

M3 - Journal article

SN - 0923-7534

VL - 22

SP - 1973

EP - 1980

JO - Annals of Oncology

JF - Annals of Oncology

IS - 9

ER -

1st ESMO Consensus Conference in lung cancer; Lugano 2010: small-cell lung cancer

Abstract

FN’s Verdensmål

Adgang til dokumentet

Fingeraftryk

Citationsformater